#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Marginal zone lymphoma recurrent Factor VIII deficiency Canavan disease Laryngeal squamous cell carcinoma Squamous cell carcinoma of head and neck Myelofibrosis Hereditary angioedema Pleomorphic liposarcoma Pulmonary alveolar haemorrhage Autoinflammation with infantile enterocolitis Brain abscess Non-small cell lung cancer metastatic Bone marrow disorder Stiff person syndrome Turner's syndrome More trials…

    Learn about Rare Diseases

    Hereditary hypophosphataemic rickets – Basic Information Primary immunodeficiency syndrome – Life with Disease Glomerulonephritis membranoproliferative – Treatment Aicardi-Goutieres syndrome – Trials in Disease Angiosarcoma metastatic – Basic Information Angiosarcoma – Trials in Disease Synovial sarcoma metastatic – Life with Disease Lymphatic malformation – Life with Disease Aicardi-Goutieres syndrome – Diagnostics Glycogen storage disease type I – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Simoctocog Alfa M2Rlab Amlitelimab Sodium Thiosulfate Mezigdomide Stx-241 NORETHISTERONE ACETATE VANADIUM OXIDE SULFATE Avalotcagene Ontaparvovec Vafidemstat Rapcabtagene Autoleucel Zibotentan Cabergoline GRNA-001 Piperacillin Sodium Estriol Povidone, Iodinated Loperamide Sabestomig Busulfan More therapies…

    Learn about Your Condition

    Urethral valves Chronic fatigue syndrome Senile dementia Inflammatory bowel disease Follicular lymphoma stage IV Rheumatoid arthritis Small cell carcinoma Richter's syndrome Large cell lung cancer stage 0 Impaired gastric emptying Muscle injury Deafness Placenta praevia Lung adenocarcinoma stage III Herpes simplex meningitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University General Hospital Of Thessaloniki Ahepa

University General Hospital Of Thessaloniki Ahepa

1st St Kiriakidis Str, Thessaloniki, 546 36, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Brinzolamide and Timolol Eye Drops for Patients with Glaucoma or Ocular Hypertension

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Brinzolamide
    • Timolol
    Greece

  • Study on the Effectiveness of NNC0194-0499 and Semaglutide in Treating Non-Alcoholic Steatohepatitis (NASH) in Patients with Fibrosis Stages 2-4

    Not recruiting

    2 1
    Investigated Drugs:
    • Nnc0194-0499
    • Cagrilintide
    • Semaglutide
    Belgium Bulgaria Czechia Denmark France Germany +5

  • Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Belgium Bulgaria Czechia Denmark France Germany +9

  • Study Comparing ABBV-383 with Standard Therapies for Adults with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Diphenhydramine
    • Selinexor
    • Bortezomib
    Austria Belgium Czechia Denmark France Germany +7

  • Study on the Effectiveness and Safety of Ralinepag for Patients with Pulmonary Arterial Hypertension

    Not recruiting

    3 1
    Investigated Diseases:
    • Pulmonary hypertension
    Investigated Drugs:
    • Ralinepag
    Austria Belgium Bulgaria Czechia Denmark France +9

  • Study on Long-term Safety of Seralutinib for Patients with Pulmonary Arterial Hypertension

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Pulmonary arterial hypertension
    Investigated Drugs:
    • Seralutinib
    Austria Belgium Czechia Denmark France Germany +10

  • Study on the Long-term Safety and Efficacy of Ralinepag for Patients with Pulmonary Arterial Hypertension

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Pulmonary hypertension
    Investigated Drugs:
    • Ralinepag
    Austria Belgium Bulgaria Czechia Denmark France +9

  • Study on the Effectiveness and Safety of Oral Semaglutide Compared to Placebo in Children and Adolescents with Type 2 Diabetes Using Metformin or Basal Insulin

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Semaglutide
    Austria Czechia Greece The Netherlands Portugal Romania

  • Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Iclepertin
    Austria Belgium Bulgaria Croatia Czechia Denmark +15

  • Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Charcoal, Activated
    • Colestyramine
    • Magnesium Citrate
    Bulgaria Croatia Czechia Estonia France Germany +9
Previous Page
1 … 11 12 13 14 15
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!